| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.3M | — | +13.2% |
| R&D Expense | $2.4M | — | +95.6% |
| SG&A Expense | $5.5M | — | +26.9% |
| Operating Income | $1.0M | — | -50.5% |
| Pre-tax Income | $974K | — | -51.0% |
| Income Tax | $52K | — | +26.8% |
| Net Income | $922K | — | -52.7% |
| EPS (Basic) | -$0.01 | — | +75.0% |
| EPS (Diluted) | -$0.01 | — | +75.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $15.2M | +1.2% | +9.7% |
| Inventory | $432K | -14.8% | -29.1% |
| Current Assets | $26.1M | +1.4% | -8.8% |
| Total Assets | $86.7M | -1.0% | +17.9% |
| Current Liabilities | $23.5M | -3.9% | +38.4% |
| Total Liabilities | $28.4M | +1.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.6M | — | -29.4% |
| Capital Expenditures | $412K | — | -34.0% |
| Investing Cash Flow | -$1.2M | — | +18.4% |
| Financing Cash Flow | -$2.1M | — | -11.3% |
| Free Cash Flow | $3.2M | — | -28.7% |
| +46.5% |
| Stockholders' Equity | $58.3M | -2.0% | +7.7% |